ADUS Stock Analysis: Buy, Sell, or Hold?
ADUS - Addus HomeCare Corp.
$120.81
0.26 (0.22%)
▲
5d:
+4.09%
30d:
+7.94%
90d:
+29.54%
HOLD
MODERATE Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 03, 2026
0d
Get Alerted When ADUS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ADUS is fairly valued with market pricing in 3.7% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: ADUS is fairly valued with market pricing in 3.7% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$140.47
Based on 5.4% avg growth
INTRINSIC VALUE TODAY
$87.22
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ADUS is currently trading at $120.81, which is considered extended relative to its 30-day fair value range of $112.78 to $119.19. From a valuation perspective, the stock is trading at a premium (Forward PE: 16.1) compared to its historical average (14.4). At these levels, the market is pricing in 3.7% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ADUS is in a strong uptrend. The price is approaching resistance at $123.14. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $134.69 (+11.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ADUS is in a strong uptrend. The price is approaching resistance at $123.14. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $134.69 (+11.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$112.78 -
$119.19
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
49.5%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (47/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($134.69)
- NEUTRAL: Market pricing in 3.7% annual earnings growth - fairly valued
- NEUTRAL: Bottoming setup forming (47/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$112.78 -
$119.19
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$114.12
Resistance Level
$123.14
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.07
Wall Street Target
$134.69
(+11.5%)
Revenue Growth (YoY)
8.0%
Earnings Growth (YoY)
24.2%
Profit Margin
7.1%
Valuation Premium vs History
+3.7% premium
PE vs Historical
16.1 vs 14.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.7%
(market-implied from PE analysis)
1-Year Target
$125.28
(+4%)
2-Year Target
$129.92
(+8%)
3-Year Target
$134.72
(+12%)
3-Yr Target (if PE normalizes)
(PE: 16→14)
PE COMPRESSION
$120.74
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 6.7%)
$183.45
(+52%)
Base:
(SPY PE: 16.1, Growth: 6.7%)
$146.87
(+22%)
Bear:
(PE: 13.7, Growth: 6.7%)
$124.84
(+3%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (21x PE), but valuation improves significantly next year (16x PE) as earnings recover.
Trailing PE: 21.04 | Current EPS (TTM): $5.73
Bull Case
$174.00
(+44%)
Analyst growth 31.2%, PE expands to 23.1
Base Case
$158.18
(+31%)
Market implied 31.2%, PE stable at 21.0
Bear Case
$81.97
(-32%)
Severe decline -20.0%, PE contracts to 17.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 22, 2026 6:05 PM ET
Data refreshes hourly during market hours. Next update: 7:05 PM
Data refreshes hourly during market hours. Next update: 7:05 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADUS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
19
Sells
Net
INSIDERS SELLING
Recent Transactions
Cliff Donald Blessing
SELL
178 shares
2026-04-21
Brian Poff
SELL
820 shares
2026-02-25
Cliff Donald Blessing
SELL
177 shares
2026-02-25
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$282 | 37 SELL |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$455 | 44 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 47 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 42 HOLD |
|
SGRY
Surgery Partners Inc |
STRONG BUY
12 analysts |
$19 | 58 HOLD |
